Chinese RCBs: Two Bailouts. How Many More At Risk?
This is largely an objective insight. There can be no guarantee/certainty why one bank may need to hoist the white flag, while another does not....
509 Views
Shanghai Henlius (复宏汉霖) IPO: Thoughts on Price Range, Cornerstone, Valuation Trap
Shanghai Henlius, a biotech subsidiary of Fosun Pharma, launched book building today to raise up to USD 477 million. In our previous insights...
1.1k Views
Bank of Hangzhou: The Tide Must Reach Its Lowest Before It Turns
While Bank of Hangzhou Co Ltd (600926 CH) may tick the boxes for fundamental progression and valuation, we remain on the sidelines.The bank does...
595 Views
Bank of Jiujiang: More Sceptical than Trusting
Bank Of Jiujiang (6190 HK) may have a limited "free float" but the bank is illustrative of issues today within specific areas of the Chinese...
497 Views
China Banks – After IPO, It Takes 2-3 Years for Impairments to Surpass Funds Raised
We know that banks often raise capital to boost capital adequacy. That is normal. But we also know that banks often use this as the premise, but...
649 Views